{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:27:25Z","timestamp":1782811645221,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,19]]},"DOI":"10.7759\/cureus.74053","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T06:49:12Z","timestamp":1732085352000},"source":"Crossref","is-referenced-by-count":2,"title":["Bactrim-Induced Hepatotoxicity"],"prefix":"10.7759","author":[{"given":"Henry","family":"Onyirimba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava L","family":"Boudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Boudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie S","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Brian","family":"Boudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-1-44","article-title":"Sulfamethoxazole\/trimethoprim induced liver failure: a case report","volume":"1","author":"Abusin S","year":"2008","unstructured":"Abusin S, Johnson S. Sulfamethoxazole\/trimethoprim induced liver failure: a case report. Cases J. 2008, 1:44. 10.1186\/1757-1626-1-44","journal-title":"Cases J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.5.539","article-title":"Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient","volume":"30","author":"Bell TL","year":"2010","unstructured":"Bell TL, Foster JN, Townsend ML. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient. Pharmacotherapy. 2010, 30:539. 10.1592\/phco.30.5.539","journal-title":"Pharmacotherapy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee WM","year":"2003","unstructured":"Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003, 349:474-85. 10.1056\/NEJMra021844","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00365528209182041","article-title":"Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs","volume":"17","author":"D\u00f8ssing M","year":"1982","unstructured":"D\u00f8ssing M, Andreasen PB. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs. Scand J Gastroenterol. 1982, 17:205-11. 10.3109\/00365528209182041","journal-title":"Scand J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.920","article-title":"Research, innovations, clinical vignettes competition. Abstracts of Hospital Medicine Dallas 2011. May 10-13, 2011. Grapevine, Texas, USA","volume":"6 Suppl 2","year":"2011","unstructured":"Research, innovations, clinical vignettes competition. Abstracts of Hospital Medicine Dallas 2011. May 10-13, 2011. Grapevine, Texas, USA. J Hosp Med. 2011, 6 Suppl 2.S1-279. 10.1002\/jhm.920","journal-title":"J Hosp Med"},{"key":"ref6","unstructured":"Drug-induced liver disease. (2022). Accessed. March 8, 2022: https:\/\/emedicine.medscape.com\/article\/169814-overview?form=fpf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2013.811588","article-title":"Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology","volume":"51","author":"Seger D","year":"2013","unstructured":"Seger D, Barker K, McNaughton C. Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology. Clin Toxicol (Phila). 2013, 51:461-6. 10.3109\/15563650.2013.811588","journal-title":"Clin Toxicol (Phila)"},{"key":"ref8","article-title":"Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome","volume":"10","author":"Mainra RR","year":"2003","unstructured":"Mainra RR, Card SE. Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome. Can J Clin Pharmacol. 2003, 10:175-8.","journal-title":"Can J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.032","article-title":"Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives","volume":"146","author":"Fontana RJ","year":"2014","unstructured":"Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014, 146:914-28. 10.1053\/j.gastro.2013.12.032","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2016.1127756","article-title":"Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review","volume":"10","author":"Stine JG","year":"2016","unstructured":"Stine JG, Lewis JH. Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol. 2016, 10:517-36. 10.1586\/17474124.2016.1127756","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2003.00040.x","article-title":"Successful orthotopic liver transplantation after trimethoprim-sulfamethoxazole associated fulminant liver failure","volume":"17","author":"Zaman F","year":"2003","unstructured":"Zaman F, Ye G, Abreo KD, Latif S, Zibari GB. Successful orthotopic liver transplantation after trimethoprim-sulfamethoxazole associated fulminant liver failure. Clin Transplant. 2003, 17:461-4. 10.1034\/j.1399-0012.2003.00040.x","journal-title":"Clin Transplant"},{"key":"ref12","article-title":"Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole","volume":"89","author":"Altraif I","year":"1994","unstructured":"Altraif I, Lilly L, Wanless IR, Heathcote J. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Am J Gastroenterol. 1994, 89:1230-4.","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20081","article-title":"Hy's law","volume":"39","author":"Reuben A","year":"2004","unstructured":"Reuben A. Hy's law. Hepatology. 2004, 39:574-8. 10.1002\/hep.20081","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson E","year":"2005","unstructured":"Bj\u00f6rnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005, 42:481-9. 10.1002\/hep.20800","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-30105","article-title":"Epidemiology and individual susceptibility to adverse drug reactions affecting the liver","volume":"22","author":"Larrey D","year":"2002","unstructured":"Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis. 2002, 22:145-55. 10.1055\/s-2002-30105","journal-title":"Semin Liver Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade RJ","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fern\u00e1ndez MC, et al.. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005, 129:512-21. 10.1016\/j.gastro.2005.05.006","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13593","article-title":"Drug induced liver injury with analysis of alternative causes as confounding variables","volume":"84","author":"Teschke R","year":"2018","unstructured":"Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol. 2018, 84:1467-77. 10.1111\/bcp.13593","journal-title":"Br J Clin Pharmacol"},{"key":"ref18","article-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","author":"Zimmerman HJ","year":"1999","unstructured":"Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. Lippincott Williams & Wilkins, Philadelphia, PA; 1999."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.030","article-title":"Are patients with elevated liver tests at increased risk of drug-induced liver injury?","volume":"126","author":"Russo MW","year":"2004","unstructured":"Russo MW, Watkins PB. Are patients with elevated liver tests at increased risk of drug-induced liver injury?. Gastroenterology. 2004, 126:1477-80. 10.1053\/j.gastro.2004.03.030","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1211","article-title":"Hy's law: predicting serious hepatotoxicity","volume":"15","author":"Temple R","year":"2006","unstructured":"Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf. 2006, 15:241-3. 10.1002\/pds.1211","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87899-bactrim-induced-hepatotoxicity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T06:49:16Z","timestamp":1732085356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87899-bactrim-induced-hepatotoxicity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.74053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}